ACNU–cisplatin Continuous Infusion Chemotherapy as Salvage Therapy for Recurrent Glioblastomas: Phase II Study

Author： Gwak Ho-Shin   Youn Sang-Min   Kwon Austin-Hyuk   Lee Seung   Kim Jong   Rhee Chang  

Publisher： Springer Publishing Company

ISSN： 0167-594X

Source： Journal of Neuro-Oncology, Vol.75, Iss.2, 2005-11, pp. : 173-180

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II clinical study of irinotecan and cisplatin as first-line chemotherapy in metastatic or recurrent cervical cancer

By Chitapanarux I.   Tonusin A.   Sukthomya V.   Charuchinda C.   Pukanhapan N.   Lorvidhaya V.  

Gynecologic Oncology, Vol. 89, Iss. 3, 2003-06 ,pp. : 402-407

Elsevier

Access to resources Recommend Favorite

Weekly Chemotherapy with Cisplatin and Paclitaxel and Concurrent Radiation Therapy as Preoperative Treatment in Locally Advanced Esophageal Cancer: A Phase II Study

By Orditura Michele   Galizia Gennaro   Napolitano Vincenzo   Martinelli Erika   Pacelli Roberto   Lieto Eva   Aurilio Gaetano   Vecchione Loredana   Morgillo Floriana   Catalano Giuseppe   Ciardiello Fortunato   Genio Alberto Del   Martino Natale Di   De Vita Ferdinando  

Cancer Investigation, Vol. 28, Iss. 8, 2010-09 ,pp. : 820-827

Informa Healthcare

Access to resources Recommend Favorite

A Phase II Study of Continuous Infusion 5-Fluorouracil (5-FU) with Epirubicin and Cisplatin in Metastatic, Hormone-resistant Prostate Cancer: an Active New Regimen

By Chao D.   von Schlippe M.   Harland S.J.  

European Journal of Cancer, Vol. 33, Iss. 8, 1997-07 ,pp. : 1230-1233

Elsevier

Access to resources Recommend Favorite

Phase II Evaluation of 24-h Continuous Infusion Topotecan in Recurrent, Potentially Platinum-Sensitive Ovarian Cancer: A Gynecologic Oncology Group Study

By Markman M.   Blessing J.A.   Alvarez R.D.   Hanjani P.   Waggoner S.   Hall K.  

Gynecologic Oncology, Vol. 77, Iss. 1, 2000-04 ,pp. : 112-115

Elsevier

Access to resources Recommend Favorite

Phase II study of metronomic chemotherapy with bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy

By Reardon David   Desjardins Annick   Peters Katherine   Gururangan Sridharan   Sampson John   Rich Jeremy   McLendon Roger   Herndon James   Marcello Jennifer   Threatt Stevie   Friedman Allan   Vredenburgh James   Friedman Henry  

Journal of Neuro-Oncology, Vol. 103, Iss. 2, 2011-06 ,pp. : 371-379

Springer Publishing Company

Access to resources Recommend Favorite